A nationwide survey of past hepatitis A infections among Canadian adults

Vaccine

Volumn 28, Issue 32, 2010, Pages 5174-5178

  Scheifele, David W ^a   De Serres, Gaston ^b   Gilca, Vladimir ^b   Duval, Bernard ^b   Milner, Ruth ^a   Ho, Margaret ^a   Ochnio, Jan J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Hepatitis A; Hepatitis A vaccine; Hepatitis antibodies

Indexed keywords

HEPATITIS A ANTIBODY;

ADULT; AGED; ARTICLE; CANADA; CLINICAL ASSESSMENT; EDUCATIONAL STATUS; ENDEMIC DISEASE; ETHNICITY; FEMALE; FLUID INTAKE; GROUPS BY AGE; HEALTH SURVEY; HEPATITIS A; HUMAN; INCOME; INFECTION RISK; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; TRAVEL; VACCINATION; ADOLESCENT; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CANADA; FEMALE; HEALTH SURVEYS; HEPATITIS A; HEPATITIS A ANTIBODIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; TRAVEL; YOUNG ADULT;

EID: 77954958457     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.05.076     Document Type: Article

References (22)

1. Wu J., Zou S., Giulivi A. Current hepatitis A status in Canada. Can J Infect Dis Med Microbiol 2001, 12:341-344.
2. Ochnio J.J., Patrick D., Ho M., Dobson S.R. Vancouver street youth, injection drug users, men who have sex with men: implications for vaccination programs. Can Med Assoc J 2001, 165:293-297.
3. Harb J., Lem M., Fyfe M., Patrick D., Ochnio J., Dobson S., Hockin J. Hepatitis A outbreak in the Northern Interior of British Columbia: an outbreak among members of a First Nations community. Can Commun Dis Report 2000, 26:157-161.
4. Moses S., Mestery K., Kaita K.D., Minuk G.Y. Viral hepatitis in a Canadian street-involved population. Can J Public Health 2002, 93:123-128.
5. Alter M.J., Mares A., Hadler S.C., Maynard J.E. The effect of under-reporting on the incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987, 125:133-139.
6. Maynard J.E., Bradley D.W., Hornbeck C.L., Fields R.M., Doto I.L., Hollinger F.B. Preliminary serologic studies of antibody to hepatitis A virus in populations in the United States. J Infect Dis 1976, 134:528-530.
7. Pham B., Duval B., De Serres G., Gilca V., Tricco A.C., Ochnio J., Scheifele D.W. Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review. BMC Infect Dis 2005, 5:56.
8. Koff R.S. Seroepidemiology of hepatitis A in the United States. J Infect Dis 1995, 171(Suppl. 1):S19-S23.
9. Ochnio J.J., Scheifele D.W., Marion S.A., Bigham M., Patrick D.M., Ho M., Mozel M. Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A antibodies in adults. Can J Public Health 2007, 98:37-40.
10. Duval B., De Serres G., Ochnio J., Scheifele D., Gilca V. Nationwide Canadian study of hepatitis A antibody prevalence among children eight to thirteen years old. Pediatr Infect Dis J 2005, 24:514-519.
11. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978, 73:40-46.
12. Ochnio J.J., Scheifele D.W., Ho M., Mitchell L.A. New, ultrasensitive enzyme immunoassay for detection of vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva. J Clin Microbiol 1997, 35:98-101.
13. Duval B., De Serres G., Shadmani R., Boulianne N., Pohani G., Naus M., et al. A population-based comparison between travelers who consulted travel clinics and those who did not. J Travel Med 2003, 10:4-10.
14. Van Damme P., Leroux-Roels G., Law B., Diaz-Mitoma F., Desombere I., Collard F., et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 2001, 65:6-13.
15. Levy I., Chen D., Sherman M., Smith D., Krajden M. Hepatitis A virus seroprevalence in 1,000 university students in Toronto. Can Commun Dis Report 2001, 27:93-96.
16. Bell B.P., Kruszon-Moran D., Shapiro C.N., Lambert S.B., McQuillan G.M., Margolis H.S. Hepatitis A virus infection in the United States: serologic results from the Third National Health & Nutrition Examination Survey. Vaccine 2005, 23:5798-5806.
17. Payment P. Antibody levels to selected enteric viruses in a French-Canadian population in the province of Quebec. Immunol Infect Dis 1991, 1:317-322.
18. Bell B.P., Shapiro C.N., Alter M.J., Moyer L.A., Judson F.N., Mottram K., et al. The diverse patterns of hepatitis A epidemiology in the United States - implications for vaccination strategies. J Infect Dis 1998, 178:1579-1584.
19. De Serres G., Duval B., Shadmani R., Boulianne N., Pohani G., Naus M., et al. Ineffectiveness of the current strategy to prevent hepatitis A in travelers. J Travel Med 2002, 9:10-16.
20. Teitelbaum P. An estimate of the incidence of hepatitis A in unimmunized Canadian travelers to developing countries. J Travel Med 2004, 11:102-106.
21. Furesz J., Scheifele D.W., Palkonyay L. Safety and effectiveness of the new inactivated hepatitis A virus vaccine. Can Med Assoc J 1995, 152:343-348.
22. Potthoff R.F. Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol 1994, 139:967-978.